These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 1913652
21. Physical evidence of Mcs5, a QTL controlling mammary carcinoma susceptibility, in congenic rats. Samuelson DJ, Haag JD, Lan H, Monson DM, Shultz MA, Kolman BD, Gould MN. Carcinogenesis; 2003 Sep; 24(9):1455-60. PubMed ID: 12844486 [Abstract] [Full Text] [Related]
22. Mammary carcinoma suppressor and susceptibility genes in the Wistar-Kyoto rat. Haag JD, Newton MA, Gould MN. Carcinogenesis; 1992 Oct; 13(10):1933-5. PubMed ID: 1423858 [Abstract] [Full Text] [Related]
29. Spontaneous mammary tumors in aging Noble rats. Cheung SY, Choi HL, James AE, Chen ZY, Huang Y, Chan FL. Int J Oncol; 2003 Feb 01; 22(2):449-57. PubMed ID: 12527947 [Abstract] [Full Text] [Related]
30. Genetic regulation of mammary carcinogenesis in the rat by susceptibility and suppressor genes. Gould MN, Zhang R. Environ Health Perspect; 1991 Jun 01; 93():161-7. PubMed ID: 1773787 [Abstract] [Full Text] [Related]
31. Fine mapping reveals multiple loci and a possible epistatic interaction within the mammary carcinoma susceptibility quantitative trait locus, Mcs5. Samuelson DJ, Aperavich BA, Haag JD, Gould MN. Cancer Res; 2005 Nov 01; 65(21):9637-42. PubMed ID: 16266982 [Abstract] [Full Text] [Related]
32. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H. Cell Growth Differ; 1990 Sep 01; 1(9):407-20. PubMed ID: 1981145 [Abstract] [Full Text] [Related]
33. Site of expression and biological function of the rat mammary carcinoma suppressor gene. Zhang R, Haag JD, Gould MN. Carcinogenesis; 1990 Oct 01; 11(10):1765-70. PubMed ID: 2119906 [Abstract] [Full Text] [Related]
34. Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial-mesenchymal transition and tumorigenesis. Ward KR, Zhang KX, Somasiri AM, Roskelley CD, Schrader JW. Oncogene; 2004 Feb 12; 23(6):1187-96. PubMed ID: 14961075 [Abstract] [Full Text] [Related]
35. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ, Sebti SM. Oncogene; 2000 Nov 09; 19(47):5338-47. PubMed ID: 11103935 [Abstract] [Full Text] [Related]
36. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells. Huber BE, Cordingley MG. Oncogene; 1988 Sep 09; 3(3):245-56. PubMed ID: 3060790 [Abstract] [Full Text] [Related]
37. Inheritance and site of expression of genes controlling susceptibility to mammary cancer in an inbred rat model. Gould MN. Cancer Res; 1986 Mar 09; 46(3):1199-202. PubMed ID: 3080239 [Abstract] [Full Text] [Related]
39. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene. Takahashi C, Akiyama N, Matsuzaki T, Takai S, Kitayama H, Noda M. Oncogene; 1996 May 16; 12(10):2137-46. PubMed ID: 8668339 [Abstract] [Full Text] [Related]
40. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma. Bera TK, Tsukamoto T, Panda DK, Huang T, Guzman RC, Hwang SI, Nandi S. Biochem Biophys Res Commun; 1998 Jul 30; 248(3):835-40. PubMed ID: 9704014 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]